Pharma Journalist 8791 posts 0 comments

U.S.-based company Elanco Animal Health has entered into a definitive agreement to acquire Bayer’s Animal Health business, Bayer announced on Tuesday. The transaction is valued at 7.6…
Read More...

AstraZeneca announced positive results from the landmark Phase III DAPA-HF trial which showed that Farxiga (dapagliflozin) met the primary composite endpoint with a…
Read More...

SMi Reports: Regulation and policy to be a focus topic at the Wearable Injectors and Connected Devices conference this October The Inaugural Wearable Injectors and Connected Devices…
Read More...

The U.S. Food and Drug Administration approved Xenleta (lefamulin) to treat adults with community-acquired bacterial pneumonia. “This new drug provides another option for the…
Read More...

iBio, Inc. announced that it has entered into a Master Services Agreement with Lung Biotechnology PBC, a subsidiary of United Therapeutics Corporation, to produce recombinant human…
Read More...

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients,…
Read More...

Juvenescence, a life sciences company utilising expert drug developers and artificial intelligence experts to create therapeutics and technologies to treat diseases of aging and to…
Read More...

Nabriva Therapeutics plc announced that the U.S. Food and Drug Administration (FDA) has approved Nabriva’s new drug applications for the oral and intravenous (IV) formulations of…
Read More...

Mateon Therapeutics and PointR Data announced that they have entered into a definitive agreement with respect to a merger, creating a publicly traded artificial intelligence (“AI”)…
Read More...

Sarepta Therapeutics announced it had received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) seeking…
Read More...